Industries > Pharma > Generic Drugs Market Forecast 2018-2028

Generic Drugs Market Forecast 2018-2028

Growth in Leading Regional and National Markets – North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America, US, Canada, Germany, France, UK, Italy, Spain, India, China, Australia, South Korea, Japan, South Africa, Saudi Arabia, U.A.E, Brazil, Argentina, Mexico

PUBLISHED: 25 April 2018
PAGES: 254
PRODUCT CODE: PHA0305

Clear
WOOCS 2.2.1

The generic drugs market is estimated at $257.3bn in 2017 and is expected to grow at a CAGR of 7.9% from 2017 to 2028. The generic drugs market is expected to grow at a CAGR of 7.2% in the second half of the forecast period.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 254-page report you will receive 66 tables and 84 figures– all unavailable elsewhere.

The 254-page report provides clear detailed insight into the generic drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Generic Drugs Market forecasts from 2018-2028

• Generic Drugs Regional Market and National Market forecasts from 2018-2028, covering:
• North America: US & Canada
• Europe: Germany, UK, France, Italy, Spain, Rest of Europe
• Asia-Pacific: Japan, Australia, India, China, South Korea, Rest of Asia-Pacific
• Middle East & Africa: South Africa, Saudi Arabia, U.A.E, Rest of Middle East & Africa
• Latin America: Brazil, Argentina, Mexico, Rest of Latin America

Generic Drugs Market Forecast 2018-2028

• SWOT Analysis and Porter’s Five Forces Analysis of the generic drugs market.

• Assessment of selected leading companies that hold major market shares in the generic drugs market.
• Teva
• Novartis (Sandoz)
• Allergan
• Mylan
• Pfizer
• Abbott
• Sun Pharma
• Aspen
• Fresenius Kabi
• Sanofi
• Dr. Reddy’s Laboratories
• Apotex

Visiongain’s study is intended for anyone requiring commercial analyses for the Generic Drugs Market. You find data, trends and predictions.

Buy our report today Generic Drugs Market Forecast 2018-2028: Growth in Leading Regional and National Markets – North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America, US, Canada, Germany, France, UK, Italy, Spain, India, China, Australia, South Korea, Japan, South Africa, Saudi Arabia, U.A.E, Brazil, Argentina, Mexico.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Generic Drugs Market Forecast 2018-2028


Download sample pages

Complete the form below to download your free sample pages for Generic Drugs Market Forecast 2018-2028


Latest Pharma news

Visiongain Publishes Single-Cell Analysis Market Report 2022-2032

The global single cell analysis market was valued at US$3,255.0 million in 2022 and is projected to grow at a CAGR of 15.1% during the forecast period 2022-2032.

26 May 2022

READ

Visiongain Publishes Ophthalmic Devices Market Report 2022-2032

The number of people who are blind or have poor vision is expected to rise considerably in the coming years. The growing elderly population is one of the key drivers of the Ophthalmic Devices Market’s upward trend.

19 April 2022

READ

Visiongain Publishes Vaccine Contract Manufacturing Market Report 2022-2032

The growing global health system has made significant contributions to protecting and promoting human health. However, long-standing, developing, and reemerging infectious disease risks continue to plague the planet

13 April 2022

READ

Visiongain Publishes Pharmaceutical Contract Manufacturing Market Report 2022-2032

The major driving factor contributing towards the growth of pharmaceutical contract manufacturing market are increase in investments in pharmaceutical R&D, rise in number of patent expiry, rising demand of generic drugs, and investment in advanced manufacturing technologies. However, use of serialization can thwart the market growth.

13 April 2022

READ

Categories